Skip to main content
. 2022 Jun 16;8(8):1160–1168. doi: 10.1001/jamaoncol.2022.1981

Figure 2. Multiplexed Immunofluorescence (ImmunoProfile) Showing Intratumoral, Tumor-Stroma Interface, and Total CD8+ Cells, PD1+ Cells, CD8+ PD1+ Cells, and Foxp3+ Cells in Patients With Non–Small Cell Lung Cancer .

Figure 2.

Data are from patients in the Dana-Farber Cancer Institute cohort, including 384 patients with low tumor mutation burden (TMB) and 44 patients with high TMB.